Your session is about to expire
← Back to Search
Weekly Prednisolone for Duchenne Muscular Dystrophy
Study Summary
This trial found that a lower dose of intermittent oral corticosteroids (5mg/kg/week) is just as effective as the 10mg/kg/week dose.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 1 month and 30 months old.I have been treated with steroids before.I have Duchenne muscular dystrophy with high creatine kinase levels and a confirmed genetic mutation.
- Group 1: Experimental
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do I meet the qualifications for enrollment in this clinical experiment?
"This research seeks 26 children with muscular dystrophy, duchenne between 1 month of age and 30 months of age. The required criteria for eligibility include: a minimum one-month old subject, physical manifestations that are consistent with Duchenne muscular dystrophy (DMD), creatine kinase levels at least 20 times higher than the normal upper limit, and genetic mutation known to be causative for DMD."
How many participants are currently engaging in this experiment?
"Affirmative. According to clinicaltrials.gov, this medical trial is actively inviting participants and was initially announced on April 30th 2021. A total of 26 individuals must be enrolled at the single site that is associated with the study."
Do the potential side-effects of Prednisolone outweigh its benefits?
"Prednisolone has been approved by the relevant regulatory bodies, making it a safe and reliable option for patients. As such, our team rated its safety as 3 out of 3."
Is this research endeavor open to seniors above the age of 85?
"This medical trial is recruiting infants and toddlers aged between 1 Month to 30 Months. There are 60 patients under 18 years of age, while 49 individuals over 65 have been selected for the study."
Are there any available slots for participants in this ongoing experiment?
"That is accurate. According to clinicaltrials.gov, this trial was initially posted on April 30th 2021 and recently updated June 7th 2022. The research necessitates the enrollment of 26 volunteers from a single medical facility."
Share this study with friends
Copy Link
Messenger